Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 33 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
Completed
ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D
NCT00490139
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
- Locations
-
- Novartis Investigative Site Mobile, Alabama, United States
- Novartis Investigative Site Anchorage, Alaska, United States
- Novartis Investigative Site Tucson, Arizona, United States
- Novartis Investigative Site Jonesboro, Arkansas, United States
NCT01160211
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
- Locations
-
- Novartis Investigative Site Hollywood, Florida, United States
- Novartis Investigative Site Augusta, Georgia, United States
- Novartis Investigative Site Germantown, Tennessee, United States
- Novartis Investigative Site Tacoma, Washington, United States
NCT00444535
- Conditions
- Bone Diseases, Breast Diseases, Breast Neoplasms, +7 more
- Locations
-
- Novartis Investigative Site Tucson, Arizona, United States
- Novartis Investigative Site San Francisco, California, United States
- Novartis Investigative Site Hollywood, Florida, United States
- Novartis Investigative Site Tampa, Florida, United States
NCT00367471
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, +8 more
- Locations
-
- Novartis Investigative Site La Jolla, California, United States
- Novartis Investigative Site Indianapolis, Indiana, United States
- Novartis Investigative Site Greensboro, North Carolina, United States
NCT01118624
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +12 more
- Locations
-
- Providence Cancer Center Portland, Oregon, United States
- The West Clinic Memphis, Tennessee, United States
- Fakultní nemocnice Olomouc Olomouc, Czechia
- Multiscan, s.r.o. Pardubice, Czechia
NCT00263588
- Conditions
- Brain Diseases, Brain Neoplasms, Breast Diseases, +10 more
- Locations
-
- Novartis Investigative Site San Francisco, California, United States
- Novartis Investigative Site Vallejo, California, United States
- Novartis Investigative Site Denver, Colorado, United States
- Novartis Investigative Site Washington D.C., District of Columbia, United States
NCT00709761
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
- Locations
-
- Novartis Investigative Site La Verne, California, United States
- Novartis Investigative Site Long Beach, California, United States
- Novartis Investigative Site Fort Myers, Florida, United States
- Novartis Investigative Site Atlanta, Georgia, United States
NCT00790816
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
- Locations
-
- Novartis Investigative Site Scottsdale, Arizona, United States
- Novartis Investigative Site Tucson, Arizona, United States
- Novartis Investigative Site Santa Monica, California, United States
- Novartis Investigative Site Washington D.C., District of Columbia, United States
NCT00089973
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
- Locations
-
- GSK Investigational Site Jacksonville, Florida, United States
- GSK Investigational Site Indianapolis, Indiana, United States
- GSK Investigational Site Chapel Hill, North Carolina, United States
- GSK Investigational Site Pittsburgh, Pennsylvania, United States
NCT00148902
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
- Locations
-
- GSK Investigational Site Detroit, Michigan, United States
- GSK Investigational Site Nashville, Tennessee, United States
NCT00258050
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
- Locations
-
- GSK Investigational Site Lebanon, New Hampshire, United States
- GSK Investigational Site Chapel Hill, North Carolina, United States
NCT00169533
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
- Locations
-
- GSK Investigational Site Indianapolis, Indiana, United States
- GSK Investigational Site Detroit, Michigan, United States
- GSK Investigational Site Lebanon, New Hampshire, United States
- GSK Investigational Site Albuquerque, New Mexico, United States
NCT00388076
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
- Locations
-
- GSK Investigational Site New Brunswick, New Jersey, United States
- GSK Investigational Site Cleveland, Ohio, United States
- GSK Investigational Site Nashville, Tennessee, United States
NCT00650910
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
- Locations
-
- GSK Investigational Site Albuquerque, New Mexico, United States
- GSK Investigational Site Edmonton, Alberta, Canada
- GSK Investigational Site Seodaemun-gu, Seoul, South Korea
- GSK Investigational Site Seoul, South Korea
NCT00849329
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
- Locations
-
- GSK Investigational Site Greenville, South Carolina, United States
- GSK Investigational Site Seoul, South Korea
- GSK Investigational Site Songpa-gu, Seoul, South Korea
- GSK Investigational Site Hospitalet de Llobregat (Barcelona), Spain
NCT00821054
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
- Locations
-
- GSK Investigational Site Buffalo, New York, United States
- GSK Investigational Site Greenville, South Carolina, United States
- GSK Investigational Site Edmonton, Alberta, Canada
- GSK Investigational Site Montreal, Quebec, Canada
NCT00359190
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
- Locations
-
- GSK Investigational Site Miami, Florida, United States
- GSK Investigational Site Durham, North Carolina, United States
- GSK Investigational Site Allentown, Pennsylvania, United States
- GSK Investigational Site Pittsburgh, Pennsylvania, United States
Completed
A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib
NCT00996762
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
- Locations
-
- GSK Investigational Site Scottsdale, Arizona, United States
- GSK Investigational Site Tucson, Arizona, United States
- GSK Investigational Site Washington D.C., District of Columbia, United States
- GSK Investigational Site Fort Myers, Florida, United States
NCT00111787
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
- Locations
-
- GSK Investigational Site Miami, Florida, United States
- GSK Investigational Site Chicago, Illinois, United States
- GSK Investigational Site Zion, Illinois, United States
- GSK Investigational Site Houston, Texas, United States
Completed
A Dose-escalation Vaccine Trial in HER2-overexpressing Patients With High-risk Breast Cancer
NCT00058526
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
- Locations
-
- GSK Investigational Site Boca Raton, Florida, United States
- GSK Investigational Site Buffalo, New York, United States
- GSK Investigational Site Charlotte, North Carolina, United States
- GSK Investigational Site Seattle, Washington, United States